John A. Ellerton
Advanced in Hairy Cell Leukemia (HCL)
Advanced in Hairy Cell Leukemia (HCL)
6190 S Fort Apache Rd, 
Las Vegas, NV 

Overview

John Ellerton is a Hematologist in Las Vegas, Nevada. Dr. Ellerton is rated as an Advanced provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Hemochromatosis, Colorectal Cancer, Breast Cancer, Tissue Biopsy, and Bone Marrow Aspiration. Dr. Ellerton is currently accepting new patients.

His clinical research consists of co-authoring 4 peer reviewed articles and participating in 151 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 12 clinical trials in the study of Hairy Cell Leukemia (HCL).

Graduate Institution
McGill University Faculty Of Medicine
Residency
TUFT'S NEW ENGLAND MED. CENTER
Specialties
Hematology
Licenses
Internal Medicine in NV
Board Certifications
Internal Medicine
Internal Medicine (Sub: Hematology)
Internal Medicine (Sub: Hospice And Palliative Medici
Internal Medicine (Sub: Medical Oncology)
Fellowships
Tufts University/N.E. Medicial Center
University of Toronto Faculty of Medicine
Hospital Affiliations
Dignity Health - St. Rose Dominican Hospital, Rose De Lima Campus - Henderson, NV
Dignity Health - St. Rose Dominican Hospital, Siena Campus - Henderson, NV
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

OptumCare Cancer Care
6190 S Fort Apache Rd, Las Vegas, NV 89148

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


151 Clinical Trials

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma
A Randomized Phase III Study of Nivolumab After Combined Modality Therapy (CMT) in High Risk Anal Cancer
Molecular Analysis for Therapy Choice (MATCH)
A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients With Previously Treated Non-Squamous NSCLC
Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
STAMP: Surgically Treated Adjuvant Merkel Cell Carcinoma With Pembrolizumab, a Phase III Trial
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
View 49 Less Clinical Trials
Similar Doctors
Russell P. Gollard
Experienced in Hairy Cell Leukemia (HCL)
Hematology | Palliative Medicine
Experienced in Hairy Cell Leukemia (HCL)
Hematology | Palliative Medicine

OptumCare Cancer Care

4750 W Oakey Blvd, 2nd Floor, 
Las Vegas, NV 
 (7.3 miles away)
Languages Spoken:
English
Accepting New Patients

EDUCATIONDr. Gollard attended University of California, Los Angeles for his undergraduate and masters studies. In 1980, he completed his bachelors in English and received his masters in English in 1983. Dr. Gollard received his medical degree from the University of Southern California School of Medicine in 1990. He completed his internal medicine internship in 1991 at the University of Southern California and his internal medicine residency at the University of Southern California Medical Center in 1993. In 1996, Dr. Gollard completed his fellowship in the Division of Hematology and Oncology at the Scripps Clinic and Research Foundation.AREAS OF SPECIAL INTERESTSpecializes in general medical oncology, hematology, leukemia, lymphoma, sarcomas and medical humanities.EXPERIENCE Dr. Gollard is a medical oncologist-hematologist at Comprehensive Cancer Centers of Nevada (CCCN). He has served on numerous committees and boards. He also teaches for the Honors College at University of Nevada, Las Vegas (UNLV) and mentors both pre-medical and medical students.He has authored many articles for medical journals and lectured all over the United States. Dr. Gollard has also received numerous awards and accolades, including the Squibb Award for Outstanding Scientific Research, the Irving Lasky Award for Outstanding Achievement in Research and being named an Outstanding Hematologist/Oncologist by numerous publications.Prior to joining CCCN, he was an oncologist at Cancer & Blood Specialists of Nevada and previously had a private practice at Nevada Cancer Center. He has been practicing in Las Vegas since 1996.BOARD CERTIFIED Internal MedicineMedical OncologyHematologyHospice and Palliative MedicineMEMBERSHIPS IN PROFESSIONAL ASSOCIATIONSAmerican Association of Cancer ResearchAmerican College of Physicians – FellowAmerican Medical AssociationAmerican Society of Clinical OncologyAmerican Society of HematologyAmerican Society of Internal MedicineClark County Medical SocietyNevada State Medical Association. Dr. Gollard is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Acute Mountain Sickness, Alpha Thalassemia, Alpha Thalassemia X-Linked Intellectual Disability Syndrome, Childhood Iron Deficiency Anemia, and Bone Marrow Aspiration.

Vikas Gupta
Experienced in Hairy Cell Leukemia (HCL)
Hematology
Experienced in Hairy Cell Leukemia (HCL)
Hematology

Comprehensive Cancer Centers Of Nevada

9280 W Sunset Rd, Ste 100, 
Las Vegas, NV 
 (0.3 miles away)
Languages Spoken:
English
Accepting New Patients

Telehealth Visits are AvailableCancer does not just affect the patient, but the entire family. My goal is not just to provide quality cancer care and treatment to the patient, but also involve the whole family in the treatment decisions of their loved one as well as offer support. Dr. Gupta is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Protein S Deficiency, Protein C Deficiency, Congenital Antithrombin 3 Deficiency, and Hereditary Resistance to Anti-Vitamin K.

Hamidreza Sanatinia
Experienced in Hairy Cell Leukemia (HCL)
Experienced in Hairy Cell Leukemia (HCL)

Comprehensive Cancer Centers Of Nevada

9280 W Sunset Rd, Ste 100, 
Las Vegas, NV 
 (0.3 miles away)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Telehealth Visits are Available Hamidreza Sanatinia, MD is a medical oncologist at Comprehensive Cancer Centers of Nevada (CCCN). He is board certified in internal medicine and medical oncology. Cancer affects every one of us. I believe in treating the patient as if we are treating our own family members. As a physician, it is our duty to give the best and most current advice to our patients. I encourage academic discussion and the sharing of the latest research among physicians to improve the lives of our patients. We are well trained in treating diseases; but the overall care of the patient as a whole comes first.Cancer affects every one of us. I believe in treating the patient as if we are treating our own family members. As a physician, it is our duty to give the best and most current advice to our patients. I encourage academic discussion and the sharing of the latest research among physicians to improve the lives of our patients. We are well trained in treating diseases; but the overall care of the patient as a whole comes first. Dr. Sanatinia is rated as a Distinguished provider by MediFind in the treatment of Hairy Cell Leukemia (HCL). His top areas of expertise are Paget Disease of the Breast, Agranulocytosis, Chronic Familial Neutropenia, and Acute Mountain Sickness.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Ellerton's expertise for a condition
ConditionClose
      View All 9 Advanced Conditions
      View All 124 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile